Metabolic Syndrome (MetS) is a collection of disorders that increase your risk of developing serious health conditions such as heart disease, stroke, type 2 diabetes, and kidney disease.
There are five disorders that are associated with MetS and you need three of the following to be diagnosed with the syndrome.
- High Blood Pressure
- Obesity (excessive weight around the waistline)
- High LDL cholesterol (bad cholesterol) and low HDL cholesterol (good cholesterol)
- Insulin Resistance or type 2 diabetes (increased blood sugar after fasting)
- High triglycerides (fat in the blood).
Metabolic Syndrome affects approximately 20-30% of adults in Australia and can also affect adolescents and children (Health Direct, 2019).
MetS is linked to a number of different diseases such as polycystic ovaries syndrome (PCOS) (Ranasinha, et al., 2015), obstructive sleep apnea (OSA) (Lin, Q., et al., 2014)and non-alcoholic fatty liver disease (NAFLD) (Asrih & Jornayvaz, 2014), if you suffer from these conditions you have potential for an increased risk of developing the syndrome.
At AMV Nutrition I specialise in treating clients who have been diagnosed with Metabolic Syndrome or are at risk of developing the condition. I also treat the disorders associated with the syndrome. I approach the condition in a holistic manner using nutritional medicine and lifestyle modification whilst working alongside your GP to ensure your total wellbeing is carefully considered and managed.
If you feel you are at risk of developing MetS or have been diagnosed with 3 of the above conditions, please book a consultation with me.
References:
Asrih, M., & Jornayvaz, F.R. (2014). Metabolic Syndrome and non-alcoholic fatty liver disease: is insulin resistance the link? Molecular and Cellular Endocrinology, 418 (1), 55-65. https://www.sciencedirect.com/science/article/abs/pii/S0303720715000945
Health Direct. (2019). Metabolic Syndrome, retrieved from https://www.healthdirect.gov.au/metabolic-syndrome
Lin, Q., Chen, L., Yu, Y. et al. Obstructive sleep apnea syndrome is associated with metabolic syndrome and inflammation. European Archives of Oto-Rhino-Laryngology. 271, 825–831 (2014). https://doi.org/10.1007/s00405-013-2669-8
Ranasinha, S., Joham, A.E., Norma, R.J., Shaw, J.E., Zoungas, S., Boyle, J., Moran, L., & Teede, H.J. (2015). The association between Polycystic Ovary Syndrome (PCOS) and Metabolic Syndrome: a statistical modelling approach. Clinical Endocrinology, 83(6), 879-887.https://onlinelibrary.wiley.com/doi/abs/10.1111/cen.12830